Tuesday, July 14, 2009

Infectious Opportunity: Round Three

Finally, I'm back to using this weblog as an outlet for shameless self-promoting. And you all thought I'd forgotten. Pish-tosh, dear readers. Pish. Tosh!

So yes. We here at Nosedive Central are in fact gearing up for our third round of (extended) performances for Infectious Opportunity at the Brick Theater. I'm really glad we're able to have more than just four performances for this show, as it's been playing like gangbusters. I'm quite pleased and humbled by the very favorable reviews and enthusiastic audience responses to this one.

Considering Patrick and I were wondering with genuine sincerity how this would play in front of folks about a week before we opened, I'm also pleasantly surprised by the audience reaction. We thought some people may find it curious and introspective, but we didn't really expect overall approval. It is, after all, a show about a guy faking being HIV-positive that's not quite a comedy (although there are parts that are funny), definitely not an "issues" play and certainly not an outrageous carnie geek show (although a few people have found it outrageous).

These next two shows — on Sunday, Jul 19 at 3 p.m. and Tuesday, July 21 at 8 p.m. — really are our final performances before this goes up to the Great Production in the Sky, so don't make the mistake of thinking a re-extension will be taking place in August. Perhaps, sometime next year or the year after, we'll revisit/remount this show, but for all intents and purposes, we close on Tuesday.

For reals this time.

As I type this, there are still tickets available, but judging from past experience, that will change soon, so it's a good idea to get your tickets as soon as possible so as to not be left out on the skin-crawling fun that is Infectious Opportunity.

A shoulder for the world to cry on,

James "Sympathetic Confidant" Comtois

Labels: , ,


Post a Comment

<< Home

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 2.5 License.